TOBY REDDEN: Open Payments
NPI 1780091652 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 18 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $122 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $249 |
| Verona Pharma, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| PFIZER INC. | 2 | $33 |
| Medtronic, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: CARDIOMEMS, Ohtuvayre, ULTREON, JARDIANCE, ELIQUIS, LOKELMA, CAMZYOS, FARXIGA.
Industry payments across TX — which companies pay providers there.
